Skip to content

All recalls FDA

FDADrugsRecalled Status: Ongoing

Apollo Care, LLC recalls SEMAGLUTIDE 7.5mg (5mg/mL)

Class IIofficial

FDA Class II

FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.

Hazard
Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material
Products
  • SEMAGLUTIDE 7.5mg (5mg/mL)
Where it was sold

Nationwide within the U.S

Nationwide

Units affected
250 vials.
About this recall
SEMAGLUTIDE 7.5mg (5mg/mL), Glycine 7.5 mg (5mg/mL), 1.5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202. NDC 71170-721-01